Pathophysiology of Pediatric Gastroesophageal Reflux Disease: Similarities and Differences With Adults

Kornilia Nikaki1, Daniel Sifrim2

  • 1Gastroenterology Department, Great Ormond Street Hospital for Children.

Insights

Gastroesophageal reflux disease (GERD) involves stomach contents moving into the esophagus, causing symptoms. This study compares the underlying causes and symptom generation in pediatric versus adult GERD.

Area of Science:

  • Gastroenterology
  • Pediatric Gastroenterology
  • Physiology

Background:

  • Gastroesophageal reflux (GER) is the passage of gastric contents into the esophagus.
  • Gastroesophageal reflux disease (GERD) occurs when GER causes troublesome symptoms or complications.
  • The Montreal consensus definition (2006) focuses on symptoms, encompassing various phenotypes from functional heartburn to esophagitis.

Purpose of the Study:

  • To systematically describe the mechanisms of reflux event generation and clearance.
  • To discuss the mechanisms involved in symptom generation in GERD.
  • To compare the pathophysiology of pediatric GERD with adult GERD.

Main Methods:

  • Systematic review of mechanisms for reflux event generation and clearance.
  • Analysis of mechanisms contributing to GERD symptom generation.
  • Comparative analysis of pediatric and adult GERD pathophysiology.

Main Results:

  • Detailed description of reflux event generation and clearance mechanisms.
  • Explanation of how reflux leads to symptoms in different GERD phenotypes.
  • Identification of similarities and differences between pediatric and adult GERD.

Conclusions:

  • GERD pathophysiology is multifactorial, involving complex interactions.
  • Understanding distinct pediatric and adult mechanisms is crucial for targeted management.
  • Further research into comparative pathophysiology can refine diagnostic and therapeutic strategies.

Related Concept Videos

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
616
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
31
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
256
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
35
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
319
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
38